🇺🇸 FDA
Pipeline program

Percutaneous transhepatic biliary stenting with conventional linear ^125^I seeds strand

LLSC20221301

Unknown other completed

Quick answer

Percutaneous transhepatic biliary stenting with conventional linear ^125^I seeds strand for Malignant Obstructive Jaundice is a Unknown program (other) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Malignant Obstructive Jaundice
Phase
Unknown
Modality
other
Status
completed

Clinical trials